| cation transport | GO:0006812 | 399 | 0.933 | Mouse |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.889 | |
| negative regulation of serotonin secretion | GO:0014063 | 2 | 0.867 | |
| histamine induced gastric acid secretion | GO:0001697 | 1 | 0.857 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.842 | |
| gastrin induced gastric acid secretion | GO:0001698 | 1 | 0.836 | |
| learning or memory | GO:0007611 | 148 | 0.835 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.814 | |
| gtp catabolic process | GO:0006184 | 143 | 0.791 | |
| operant conditioning | GO:0035106 | 2 | 0.785 | |
| phospholipase c activating serotonin receptor signaling pathway | GO:0007208 | 1 | 0.783 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.775 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.768 | |
| learning | GO:0007612 | 98 | 0.754 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.753 | |
| regulation of cell migration | GO:0030334 | 219 | 0.753 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.746 | |
| positive regulation of heart rate by epinephrine norepinephrine | GO:0001996 | 4 | 0.731 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.726 | |
| g protein coupled receptor internalization | GO:0002031 | 3 | 0.721 | |
| associative learning | GO:0008306 | 61 | 0.720 | |
| gtp metabolic process | GO:0046039 | 144 | 0.712 | |
| cognition | GO:0050890 | 149 | 0.708 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.705 | |
| memory | GO:0007613 | 58 | 0.700 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.684 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.679 | |
| sensitization | GO:0046960 | 2 | 0.665 | |
| vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure | GO:0002025 | 3 | 0.644 | |
| synaptic transmission | GO:0007268 | 329 | 0.641 | Mouse Rat Fly |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.640 | |
| regulation of saliva secretion | GO:0046877 | 2 | 0.636 | |
| urogenital system development | GO:0001655 | 261 | 0.636 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.630 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.617 | |
| regulation of systemic arterial blood pressure by norepinephrine epinephrine | GO:0001993 | 8 | 0.617 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.613 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.605 | |
| visual behavior | GO:0007632 | 45 | 0.596 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.591 | |
| insulin secretion | GO:0030073 | 89 | 0.591 | |
| cellular response to temperature stimulus | GO:0071502 | 2 | 0.590 | |
| serotonin receptor signaling pathway | GO:0007210 | 8 | 0.582 | |
| corticotropin releasing hormone secretion | GO:0043396 | 2 | 0.581 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.576 | |
| positive regulation of the force of heart contraction by epinephrine norepinephrine | GO:0001997 | 3 | 0.574 | |
| sensory perception | GO:0007600 | 245 | 0.567 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.565 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.564 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.563 | |
| conditioned taste aversion | GO:0001661 | 4 | 0.556 | |
| amine metabolic process | GO:0009308 | 45 | 0.554 | |
| positive regulation of glycolytic process | GO:0045821 | 4 | 0.549 | |
| somatostatin receptor signaling pathway | GO:0038169 | 2 | 0.542 | |
| positive regulation of the force of heart contraction by chemical signal | GO:0003099 | 3 | 0.540 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.536 | |
| cellular homeostasis | GO:0019725 | 240 | 0.531 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.530 | |
| peptide transport | GO:0015833 | 133 | 0.529 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.514 | |
| hormone secretion | GO:0046879 | 128 | 0.509 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.509 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.507 | |
| regulation of serotonin secretion | GO:0014062 | 3 | 0.495 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.492 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.485 | |
| developmental maturation | GO:0021700 | 193 | 0.485 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.477 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.475 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.475 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.469 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.457 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.434 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.421 | |
| regulation of ion transport | GO:0043269 | 215 | 0.411 | Human |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.410 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.410 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.409 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.396 | |
| positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway | GO:0051482 | 4 | 0.395 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.392 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.390 | |
| gland development | GO:0048732 | 330 | 0.382 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.381 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.380 | |
| peptide secretion | GO:0002790 | 114 | 0.373 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.371 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.370 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.370 | |
| long term synaptic potentiation | GO:0060291 | 25 | 0.365 | |
| negative regulation of purine nucleotide metabolic process | GO:1900543 | 16 | 0.361 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.359 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.356 | |
| forebrain development | GO:0030900 | 302 | 0.353 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.352 | |
| adult walking behavior | GO:0007628 | 41 | 0.352 | |
| rhythmic process | GO:0048511 | 174 | 0.348 | |
| digestion | GO:0007586 | 40 | 0.338 | |
| regulation of cell motility | GO:2000145 | 236 | 0.331 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.329 | |
| regulation of neuronal synaptic plasticity | GO:0048168 | 30 | 0.328 | |
| catecholamine transport | GO:0051937 | 21 | 0.325 | Mouse |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.320 | |
| positive regulation of heart rate | GO:0010460 | 10 | 0.318 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.311 | |
| heart morphogenesis | GO:0003007 | 178 | 0.311 | |
| adult behavior | GO:0030534 | 135 | 0.308 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.306 | |
| action potential | GO:0001508 | 78 | 0.294 | |
| hippocampus development | GO:0021766 | 52 | 0.284 | |
| endocrine system development | GO:0035270 | 98 | 0.283 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.280 | |
| regulation of tube size | GO:0035150 | 57 | 0.278 | |
| renal system development | GO:0072001 | 225 | 0.276 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.273 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.270 | |
| transmembrane transport | GO:0055085 | 412 | 0.269 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.268 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.267 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.264 | |
| limbic system development | GO:0021761 | 72 | 0.263 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.260 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.259 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.258 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.257 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.255 | |
| locomotory behavior | GO:0007626 | 195 | 0.249 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.247 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.247 | Mouse |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.246 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.246 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.243 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.243 | Mouse |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.243 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.242 | |
| digestive system development | GO:0055123 | 200 | 0.242 | |
| visual learning | GO:0008542 | 44 | 0.240 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.240 | |
| glucose homeostasis | GO:0042593 | 128 | 0.239 | |
| positive regulation of synaptic transmission glutamatergic | GO:0051968 | 8 | 0.238 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.237 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.236 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.228 | |
| kidney development | GO:0001822 | 213 | 0.227 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.227 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.227 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.226 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.224 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.224 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.220 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.219 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.217 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.216 | |
| angiogenesis | GO:0001525 | 201 | 0.215 | |
| positive regulation of blood pressure by epinephrine norepinephrine | GO:0003321 | 6 | 0.215 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.209 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.207 | |
| amide transport | GO:0042886 | 138 | 0.205 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.204 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.203 | |
| serotonin metabolic process | GO:0042428 | 8 | 0.202 | |
| dopamine metabolic process | GO:0042417 | 23 | 0.201 | |
| sodium ion transport | GO:0006814 | 73 | 0.199 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.199 | |
| ear development | GO:0043583 | 200 | 0.198 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.197 | |
| monoamine transport | GO:0015844 | 33 | 0.195 | Mouse |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.193 | |
| somatostatin signaling pathway | GO:0038170 | 2 | 0.193 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.191 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.190 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.189 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.188 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.186 | |
| positive regulation of camp biosynthetic process | GO:0030819 | 19 | 0.186 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.185 | |
| regulation of synaptic transmission glutamatergic | GO:0051966 | 19 | 0.185 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.185 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.183 | Mouse Rat Fly |
| regulation of peptide transport | GO:0090087 | 91 | 0.181 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.178 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.178 | |
| adenylate cyclase activating g protein coupled receptor signaling pathway | GO:0007189 | 30 | 0.178 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.174 | |
| neuron neuron synaptic transmission | GO:0007270 | 69 | 0.173 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.172 | |
| desensitization of g protein coupled receptor protein signaling pathway | GO:0002029 | 5 | 0.167 | |
| negative regulation of systemic arterial blood pressure | GO:0003085 | 15 | 0.167 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.166 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.165 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.165 | |
| telencephalon development | GO:0021537 | 186 | 0.165 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.164 | |
| sensory perception of pain | GO:0019233 | 47 | 0.164 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.163 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.161 | |
| response to amine | GO:0014075 | 16 | 0.159 | |
| circadian rhythm | GO:0007623 | 114 | 0.159 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.158 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.157 | |
| fat cell differentiation | GO:0045444 | 160 | 0.157 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.157 | |
| blood circulation | GO:0008015 | 195 | 0.156 | |
| negative regulation of blood pressure | GO:0045776 | 22 | 0.154 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.154 | |
| bone mineralization | GO:0030282 | 54 | 0.153 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.153 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.152 | |
| regulation of secretion | GO:0051046 | 274 | 0.150 | |
| bone remodeling | GO:0046849 | 53 | 0.150 | |
| metanephric tubule development | GO:0072170 | 18 | 0.150 | |
| regulation of corticotropin releasing hormone secretion | GO:0043397 | 2 | 0.150 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.150 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.149 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.149 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.149 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.148 | |
| positive regulation of cyclic nucleotide metabolic process | GO:0030801 | 24 | 0.148 | |
| stem cell development | GO:0048864 | 219 | 0.146 | |
| temperature homeostasis | GO:0001659 | 26 | 0.144 | |
| muscle system process | GO:0003012 | 141 | 0.144 | |
| skin development | GO:0043588 | 220 | 0.142 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.140 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.139 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.138 | |
| opioid receptor signaling pathway | GO:0038003 | 5 | 0.137 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.136 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.136 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.135 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.134 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.133 | |
| epinephrine transport | GO:0048241 | 1 | 0.132 | |
| positive regulation of rho gtpase activity | GO:0032321 | 41 | 0.131 | |
| heart contraction | GO:0060047 | 93 | 0.130 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.128 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.126 | |
| regulation of cation channel activity | GO:2001257 | 22 | 0.126 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.125 | |
| tissue homeostasis | GO:0001894 | 115 | 0.125 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.124 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.124 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.123 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.122 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.122 | |
| hair follicle development | GO:0001942 | 85 | 0.122 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.122 | |
| response to amphetamine | GO:0001975 | 16 | 0.121 | |
| saliva secretion | GO:0046541 | 6 | 0.119 | |
| regulation of lyase activity | GO:0051339 | 13 | 0.118 | |
| stem cell differentiation | GO:0048863 | 268 | 0.117 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.116 | |
| bone resorption | GO:0045453 | 38 | 0.114 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.113 | |
| regulation of adenylate cyclase activity | GO:0045761 | 10 | 0.113 | |
| neuromuscular process | GO:0050905 | 99 | 0.113 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.112 | |
| dopamine receptor signaling pathway | GO:0007212 | 16 | 0.112 | |
| tissue remodeling | GO:0048771 | 102 | 0.111 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.110 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.110 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.110 | |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.109 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.109 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.108 | |
| adrenergic receptor signaling pathway | GO:0071875 | 13 | 0.108 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.108 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.108 | Mouse |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.108 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.108 | |
| adenylate cyclase inhibiting g protein coupled receptor signaling pathway | GO:0007193 | 20 | 0.108 | Mouse |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.107 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.105 | |
| body fluid secretion | GO:0007589 | 53 | 0.105 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.104 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.104 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.104 | |
| t cell activation | GO:0042110 | 289 | 0.103 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.103 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.103 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.102 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.102 | |
| camp metabolic process | GO:0046058 | 40 | 0.102 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.101 | |
| regulation of cyclase activity | GO:0031279 | 13 | 0.100 | |
| cell division | GO:0051301 | 120 | 0.099 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.099 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.099 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.099 | |
| positive regulation of jun kinase activity | GO:0043507 | 30 | 0.098 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.098 | |
| regulation of ovulation | GO:0060278 | 3 | 0.098 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.098 | |
| skeletal system development | GO:0001501 | 356 | 0.098 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.097 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.097 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.097 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.097 | |
| cerebral cortex gabaergic interneuron migration | GO:0021853 | 6 | 0.096 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.096 | |
| habituation | GO:0046959 | 3 | 0.096 | |
| catecholamine secretion | GO:0050432 | 15 | 0.096 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.096 | |
| mapk cascade | GO:0000165 | 281 | 0.096 | |
| odontogenesis | GO:0042476 | 78 | 0.095 | |
| regulation of sodium ion transport | GO:0002028 | 29 | 0.094 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.093 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.093 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.093 | |
| circulatory system process | GO:0003013 | 197 | 0.093 | |
| cation homeostasis | GO:0055080 | 212 | 0.092 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.092 | |
| biomineral tissue development | GO:0031214 | 64 | 0.091 | |
| cellular response to lipid | GO:0071396 | 145 | 0.091 | |
| g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger | GO:0007187 | 55 | 0.091 | Mouse |
| divalent metal ion transport | GO:0070838 | 172 | 0.091 | |
| regulation of cyclic nucleotide biosynthetic process | GO:0030802 | 31 | 0.090 | |
| hormone metabolic process | GO:0042445 | 86 | 0.089 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.089 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.089 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.089 | |
| regulation of generation of precursor metabolites and energy | GO:0043467 | 38 | 0.088 | |
| metanephros development | GO:0001656 | 79 | 0.088 | |
| atrioventricular node cell fate commitment | GO:0060929 | 1 | 0.088 | |
| placenta development | GO:0001890 | 140 | 0.087 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.086 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.086 | |
| loop of henle development | GO:0072070 | 10 | 0.086 | |
| protein kinase c activating g protein coupled receptor signaling pathway | GO:0007205 | 4 | 0.085 | |
| heart process | GO:0003015 | 94 | 0.084 | |
| immune effector process | GO:0002252 | 321 | 0.084 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.084 | Rat |
| glial cell development | GO:0021782 | 54 | 0.084 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.084 | |
| feeding behavior | GO:0007631 | 62 | 0.083 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.082 | |
| regulation of ossification | GO:0030278 | 112 | 0.082 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.082 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.081 | |
| phospholipase c activating dopamine receptor signaling pathway | GO:0060158 | 5 | 0.081 | |
| adenylate cyclase activating dopamine receptor signaling pathway | GO:0007191 | 7 | 0.081 | |
| regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway | GO:0010578 | 3 | 0.081 | |
| neuron migration | GO:0001764 | 122 | 0.081 | |
| regulation of g protein coupled receptor protein signaling pathway | GO:0008277 | 37 | 0.081 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.080 | |
| metanephric epithelium development | GO:0072207 | 21 | 0.080 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.080 | |
| synaptic transmission glutamatergic | GO:0035249 | 36 | 0.080 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.080 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.079 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.078 | |
| optic nerve structural organization | GO:0021633 | 2 | 0.078 | |
| cell adhesion | GO:0007155 | 329 | 0.078 | |
| phasic smooth muscle contraction | GO:0014821 | 8 | 0.077 | |
| central nervous system neuron development | GO:0021954 | 67 | 0.076 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.076 | |
| gliogenesis | GO:0042063 | 141 | 0.076 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.076 | |
| negative chemotaxis | GO:0050919 | 14 | 0.076 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.076 | |
| renal tubule development | GO:0061326 | 87 | 0.075 | |
| positive regulation of cellular carbohydrate metabolic process | GO:0010676 | 29 | 0.075 | |
| digestive tract development | GO:0048565 | 190 | 0.075 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.074 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.074 | |
| axonogenesis | GO:0007409 | 274 | 0.074 | |
| behavioral response to cocaine | GO:0048148 | 10 | 0.074 | |
| chloride transmembrane transport | GO:1902476 | 24 | 0.074 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.074 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.074 | |
| neuronal action potential | GO:0019228 | 54 | 0.073 | |
| forebrain neuron development | GO:0021884 | 30 | 0.072 | |
| multicellular organism growth | GO:0035264 | 161 | 0.072 | |
| regulation of long term neuronal synaptic plasticity | GO:0048169 | 19 | 0.072 | |
| cerebellar cortex formation | GO:0021697 | 22 | 0.071 | |
| potassium ion transport | GO:0006813 | 52 | 0.071 | |
| tissue migration | GO:0090130 | 68 | 0.071 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.070 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.070 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.070 | |
| regulation of postsynaptic membrane potential | GO:0060078 | 48 | 0.070 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.069 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.069 | |
| camp biosynthetic process | GO:0006171 | 31 | 0.069 | |
| regulation of system process | GO:0044057 | 200 | 0.069 | |
| ossification | GO:0001503 | 216 | 0.069 | |
| response to radiation | GO:0009314 | 165 | 0.068 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.068 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.068 | |
| cytokine production | GO:0001816 | 319 | 0.068 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.068 | |
| positive regulation of camp metabolic process | GO:0030816 | 19 | 0.067 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.067 | Mouse |
| primary amino compound metabolic process | GO:1901160 | 8 | 0.067 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.067 | |
| long term synaptic depression | GO:0060292 | 13 | 0.067 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.067 | |
| regulation of inward rectifier potassium channel activity | GO:1901979 | 1 | 0.067 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.066 | |
| epithelial cell migration | GO:0010631 | 63 | 0.066 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.066 | |
| endocytosis | GO:0006897 | 168 | 0.065 | |
| synapse organization | GO:0050808 | 125 | 0.065 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.065 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.065 | |
| cerebral cortex gabaergic interneuron development | GO:0021894 | 6 | 0.065 | |
| positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway | GO:0010579 | 3 | 0.065 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.065 | |
| substrate independent telencephalic tangential migration | GO:0021826 | 8 | 0.065 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.064 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.064 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.064 | |
| actin filament organization | GO:0007015 | 113 | 0.063 | |
| vesicle localization | GO:0051648 | 86 | 0.063 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.063 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.063 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.062 | |
| positive regulation of purine nucleotide biosynthetic process | GO:1900373 | 26 | 0.062 | |
| regulation of g protein activated inward rectifier potassium channel activity | GO:1900128 | 1 | 0.062 | |
| regulation of cell division | GO:0051302 | 76 | 0.062 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.061 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.061 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.061 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.061 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.061 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.061 | |
| response to alkaloid | GO:0043279 | 34 | 0.061 | |
| spemann organizer formation | GO:0060061 | 2 | 0.061 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.061 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.060 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.060 | |
| epithelium migration | GO:0090132 | 63 | 0.060 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.060 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.060 | |
| glutamate receptor signaling pathway | GO:0007215 | 35 | 0.060 | |
| directional locomotion | GO:0033058 | 3 | 0.060 | |
| regulation of carbohydrate catabolic process | GO:0043470 | 12 | 0.059 | |
| positive regulation of vesicle fusion | GO:0031340 | 2 | 0.059 | |
| cell maturation | GO:0048469 | 127 | 0.059 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.059 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.059 | |
| endocrine process | GO:0050886 | 39 | 0.059 | |
| regulation of high voltage gated calcium channel activity | GO:1901841 | 2 | 0.059 | |
| germ cell development | GO:0007281 | 185 | 0.059 | |
| camera type eye development | GO:0043010 | 266 | 0.058 | |
| endothelial cell migration | GO:0043542 | 44 | 0.058 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.058 | |
| dentate gyrus development | GO:0021542 | 14 | 0.058 | |
| muscle tissue development | GO:0060537 | 308 | 0.058 | |
| visual perception | GO:0007601 | 52 | 0.058 | |
| response to corticosteroid | GO:0031960 | 20 | 0.058 | |
| response to light stimulus | GO:0009416 | 135 | 0.057 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.057 | |
| indole containing compound metabolic process | GO:0042430 | 12 | 0.057 | |
| cerebral cortex gabaergic interneuron differentiation | GO:0021892 | 9 | 0.057 | |
| regulation of heart rate | GO:0002027 | 36 | 0.056 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.056 | |
| positive regulation of carbohydrate metabolic process | GO:0045913 | 30 | 0.056 | |
| microtubule based process | GO:0007017 | 236 | 0.056 | |
| muscle contraction | GO:0006936 | 101 | 0.056 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.056 | |
| response to pain | GO:0048265 | 26 | 0.056 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.056 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.056 | |
| gastric acid secretion | GO:0001696 | 6 | 0.056 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.055 | |
| renal sodium ion transport | GO:0003096 | 2 | 0.055 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.055 | |
| response to steroid hormone | GO:0048545 | 56 | 0.055 | |
| interneuron migration from the subpallium to the cortex | GO:0021830 | 7 | 0.055 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.054 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.054 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.054 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.054 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.054 | |
| fear response | GO:0042596 | 33 | 0.054 | |
| negative regulation of g protein coupled receptor protein signaling pathway | GO:0045744 | 12 | 0.053 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.053 | |
| wound healing | GO:0042060 | 157 | 0.053 | |
| response to mineralocorticoid | GO:0051385 | 1 | 0.053 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.053 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.053 | |
| cerebellum development | GO:0021549 | 77 | 0.053 | |
| regulation of protein transport | GO:0051223 | 163 | 0.053 | Rat |
| regulation of digestive system process | GO:0044058 | 13 | 0.053 | |
| b cell activation | GO:0042113 | 161 | 0.052 | |
| regulation of neuron death | GO:1901214 | 134 | 0.052 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.052 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.052 | |
| regulation of smooth muscle contraction | GO:0006940 | 22 | 0.052 | |
| response to inorganic substance | GO:0010035 | 96 | 0.052 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.052 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.052 | |
| response to acid chemical | GO:0001101 | 111 | 0.051 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.051 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.051 | |
| serotonin transport | GO:0006837 | 11 | 0.051 | |
| regulation of asymmetric cell division | GO:0009786 | 4 | 0.051 | |
| nuclear division | GO:0000280 | 158 | 0.051 | |
